IL13 and chronic obstructive pulmonary disease: On the contrary, it is highly plausible that key mediators such as IL-5 and IL-13 remain central to type-2-driven airways inflammatory responses in asthmatic individuals, irrespective of the presence of the COPD-A etiotype.